Eindhoven-based Alphabeats, a digital mental wellness platform, announced on Thursday that it has secured €1.5M in a Seed round of funding led by DeepTechXL and followed-on by LUMO Labs.
Alphabeats says the funds will help it to further develop its patented technology offering EEG-based mental training to improve performance in elite athletes.
Alphabeats: What you need to know
Founded in 2019, AlphaBeats is a health tech venture that uses neurofeedback technology and a patented algorithm developed by Philips.
“Neuroscience is the future of elite athletics and top performance. We’re very excited to be at the forefront of this movement,” shares Jur Vellema, co-founder of Alphabeats.